Molnupiravir shows itself to be antiviral treatment for COVID-19. This newly developed drug acts to inhibit the replication of the SARS-CoV-2 virus, potentially reducing the severity of infection. Clinical trials have https://www.milanmedicals.com/molnupiravir-200-mg